Jinxin Fertility Group Ltd
HKEX:1951
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.09
4.42
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Jinxin Fertility Group Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | CN |
Market Cap | 8.1B HKD |
Net Margin |
11%
|
Country | US |
Market Cap | 91.8B USD |
Net Margin |
1%
|
Country | US |
Market Cap | 87.7B EUR |
Net Margin |
1%
|
Country | US |
Market Cap | 73B USD |
Net Margin |
1%
|
Country | DE |
Market Cap | 24.9B EUR |
Net Margin |
3%
|
Country | US |
Market Cap | 20.1B USD |
Net Margin |
3%
|
Country | DE |
Market Cap | 18.8B EUR |
Net Margin |
-2%
|
Country | US |
Market Cap | 18.3B USD |
Net Margin |
9%
|
Country | US |
Market Cap | 13.7B USD |
Net Margin |
7%
|
Country | DE |
Market Cap | 12.4B EUR |
Net Margin |
3%
|
Country | AU |
Market Cap | 13.4B AUD |
Net Margin |
6%
|
Jinxin Fertility Group Ltd
Glance View
Jinxin Fertility Group Ltd. engages in the provision of assisted reproductive, management and ancillary medical services. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2019-06-25. The firm operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The firm mainly operates its business in China and the Unites.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Jinxin Fertility Group Ltd's most recent financial statements, the company has Net Margin of 10.7%.